News and Updates

FDA approved the Medtronic 780G artificial pancreas system, providing automatic adjustments and corrections to blood-sugar levels.

Breakthrough T1D supports the INSULIN Act and encourages advocates to contact their Senators and urge them to support this legislation to make insulin more affordable.

Aspect and Novo Nordisk announce a partnership, using Aspect’s bioprinting technology and Novo Nordisk’s expertise, to develop treatments for diabetes.

Breakthrough T1D Advocates use the most powerful tools they have—their own personal stories—to raise awareness and power progress for the type 1 diabetes community.

JDRF’s Chief Mission Strategy Officer will leave behind quite a legacy once she steps down from her role at Breakthrough T1D at the end of March 2023.

Meet two type 1 diabetes (T1D) clinical trial participants who are helping improve lives and getting us closer to cures, one study at a time.

The Federal Government is one of Breakthrough T1D’s most important partners in advancing research to better treat, prevent, and ultimately cure type 1 diabetes (T1D). Breakthrough T1D’s annual Government Day event, held in Washington, D.C., brings together dedicated Breakthrough T1D Advocates from around the nation to use their own personal stories to communicate the financial, […]

The inaugural award goes to Senator Susan Collins (R-ME), Senator Jeanne Shaheen (D-NH), and Rep. Diana DeGette (D-CO).

Our March TypeOneNation virtual summit featured a group of incredible women with type 1 diabetes (T1D) sharing their stories about career, family, body image, and pregnancy.

Beta cell replacement therapies aim to overcome the obstacles to realize their potential, but several approaches are making them a thing of the past.